Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 3.46 +0.12 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.34 | 52 Week High | $ | |||
| Open | $3.28 | 52 Week Low | $ | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $3.26 | EPS | $ | |||
| Volume | 71,171 | |||||
| (NASDAQ: PLRZ) | Delayed: 11.71 +0.13 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.58 | 52 Week High | $ | |||
| Open | $11.84 | 52 Week Low | $ | |||
| Day High | $12.60 | P/E | N/A | |||
| Day Low | $11.71 | EPS | $ | |||
| Volume | 11,846 | |||||

